Literature DB >> 14586448

Clinical proteomics: written in blood.

Lance A Liotta1, Mauro Ferrari, Emanuel Petricoin.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14586448     DOI： 10.1038/425905a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  125 in total

1.  Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside.

Authors:  Mingming Ning; David A Sarracino; Ferdinando S Buonanno; Bryan Krastins; Sherry Chou; David McMullin; Xiaoying Wang; Mary Lopez; Eng H Lo
Journal:  Transl Stroke Res       Date:  2010-12-01       Impact factor: 6.829

Review 2.  Current advantages in the application of proteomics in inflammatory bowel disease.

Authors:  Anna Vaiopoulou; Maria Gazouli; George Theodoropoulos; George Zografos
Journal:  Dig Dis Sci       Date:  2012-06-28       Impact factor: 3.199

Review 3.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Authors:  Mary Caldorera-Moore; Nathalie Guimard; Li Shi; Krishnendu Roy
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

4.  Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.

Authors:  Claudia Fredolini; Francesco Meani; Alessandra Luchini; Weidong Zhou; Paul Russo; Mark Ross; Alexis Patanarut; Davide Tamburro; Guido Gambara; David Ornstein; Franco Odicino; Monica Ragnoli; Antonella Ravaggi; Francesco Novelli; Devis Collura; Leonardo D'Urso; Giovanni Muto; Claudio Belluco; Sergio Pecorelli; Lance Liotta; Emanuel F Petricoin
Journal:  AAPS J       Date:  2010-06-12       Impact factor: 4.009

5.  An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring.

Authors:  Rachel A Egler; Yiting Li; Tu Anh T Dang; Tricia L Peters; Eastwood Leung; Shixia Huang; Heidi V Russell; Hao Liu; Tsz-Kwong Man
Journal:  Proteomics Clin Appl       Date:  2011-09-07       Impact factor: 3.494

6.  Differential microRNA expression in the serum of patients with nephrotic syndrome and clinical correlation analysis.

Authors:  Jian Teng; Fang Sun; Peng-Fei Yu; Ji-Xia Li; Dong Yuan; Jing Chang; Shu-Hua Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 7.  Blood-borne biomarkers and bioindicators for linking exposure to health effects in environmental health science.

Authors:  M Ariel Geer Wallace; Tzipporah M Kormos; Joachim D Pleil
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2016-10-19       Impact factor: 6.393

8.  Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry.

Authors:  Qi Liu; Xuerong Chen; Chaojun Hu; Renqing Zhang; Ji Yue; Guihui Wu; Xiaoping Li; Yunhong Wu; Fuqiang Wen
Journal:  Lung       Date:  2009-12-09       Impact factor: 2.584

9.  Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome.

Authors:  Ali Bouamrani; Ye Hu; Ennio Tasciotti; Li Li; Ciro Chiappini; Xuewu Liu; Mauro Ferrari
Journal:  Proteomics       Date:  2010-02       Impact factor: 3.984

10.  Tailoring of the nanotexture of mesoporous silica films and their functionalized derivatives for selectively harvesting low molecular weight protein.

Authors:  Ye Hu; Ali Bouamrani; Ennio Tasciotti; Li Li; Xuewu Liu; Mauro Ferrari
Journal:  ACS Nano       Date:  2010-01-26       Impact factor: 15.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.